Hawkins (NASDAQ:HWKN) Reaches New 52-Week High at $92.42

Hawkins, Inc. (NASDAQ:HWKNGet Free Report) shares hit a new 52-week high during mid-day trading on Monday . The company traded as high as $92.42 and last traded at $92.42, with a volume of 10038 shares traded. The stock had previously closed at $90.30.

Analysts Set New Price Targets

Separately, BWS Financial increased their target price on Hawkins from $74.00 to $96.00 and gave the stock a “buy” rating in a report on Friday, May 17th.

Check Out Our Latest Analysis on HWKN

Hawkins Trading Up 3.1 %

The business has a fifty day moving average of $85.86 and a 200-day moving average of $76.04. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.24 and a current ratio of 1.96. The company has a market capitalization of $1.94 billion, a P/E ratio of 25.78, a PEG ratio of 4.13 and a beta of 0.72.

Hawkins (NASDAQ:HWKNGet Free Report) last issued its quarterly earnings data on Wednesday, May 15th. The specialty chemicals company reported $0.66 earnings per share for the quarter, missing the consensus estimate of $0.68 by ($0.02). Hawkins had a net margin of 8.20% and a return on equity of 19.41%. The company had revenue of $223.02 million for the quarter, compared to the consensus estimate of $217.49 million. Analysts anticipate that Hawkins, Inc. will post 3.67 earnings per share for the current fiscal year.

Hawkins Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, June 14th. Stockholders of record on Friday, May 31st were given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 0.69%. The ex-dividend date of this dividend was Friday, May 31st. Hawkins’s dividend payout ratio is presently 17.83%.

Insider Activity

In other Hawkins news, Director James A. Faulconbridge bought 1,300 shares of the firm’s stock in a transaction dated Tuesday, June 4th. The stock was purchased at an average cost of $86.50 per share, with a total value of $112,450.00. Following the transaction, the director now directly owns 38,117 shares in the company, valued at approximately $3,297,120.50. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, Director James A. Faulconbridge bought 2,000 shares of Hawkins stock in a transaction on Monday, June 10th. The stock was acquired at an average price of $86.47 per share, with a total value of $172,940.00. Following the acquisition, the director now directly owns 44,017 shares of the company’s stock, valued at $3,806,149.99. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director James A. Faulconbridge bought 1,300 shares of Hawkins stock in a transaction on Tuesday, June 4th. The shares were bought at an average cost of $86.50 per share, with a total value of $112,450.00. Following the acquisition, the director now directly owns 38,117 shares in the company, valued at $3,297,120.50. The disclosure for this purchase can be found here. Insiders acquired a total of 5,100 shares of company stock valued at $442,998 in the last ninety days. 3.80% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. AJOVista LLC purchased a new position in Hawkins during the 4th quarter valued at about $26,000. USA Financial Formulas bought a new stake in shares of Hawkins during the 4th quarter valued at about $77,000. Quest Partners LLC bought a new stake in shares of Hawkins during the 4th quarter valued at about $108,000. Shell Asset Management Co. boosted its position in shares of Hawkins by 36.9% during the 1st quarter. Shell Asset Management Co. now owns 2,342 shares of the specialty chemicals company’s stock valued at $180,000 after acquiring an additional 631 shares during the last quarter. Finally, AXS Investments LLC bought a new stake in shares of Hawkins during the 4th quarter valued at about $179,000. Hedge funds and other institutional investors own 69.71% of the company’s stock.

About Hawkins

(Get Free Report)

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.

Read More

Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.